An Atypical Case of Anti-GBM Disease with Insidious Onset (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0449; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "She was treated with mycophenolate mofetil and angiotensin receptor blockade, with only partial response and progressive urinary abnormalities...Treatment with corticosteroids, plasmapheresis, and cyclophosphamide resulted in renal recovery to baseline creatinine (1.2 mg/dL) over 9–12 months...Rituximab may be considered in refractory cases. Plasma exchange duration is uncertain due to variable responses. This case demonstrates progression from non-crescentic to crescentic disease despite immunosuppression, highlighting disease heterogeneity and need for more study."
Clinical • Asthma • CNS Disorders • Depression • Glioblastoma • Glomerulonephritis • Immunology • Lupus Nephritis • Major Depressive Disorder • Nephrology • Renal Disease • Respiratory Diseases • Vasculitis
|
|
Stefan Charles Hutson; Syed Haris Mustafa Zaidi; Grace Yun Chong
|